Literature DB >> 8165687

Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study.

P C Hannaford1, P R Croft, C R Kay.   

Abstract

BACKGROUND AND
PURPOSE: A nested case-control analysis of data collected during the prospective Royal College of General Practitioners' Oral Contraception Study was performed to examine the relation between use of oral contraception and risk of stroke.
METHODS: The 253 women who had a first-ever stroke (International Classification of Diseases, eighth revision, codes 4300 to 4389) or amaurosis fugax (code 3791) between 1968 and 1990 (case subjects) were compared with 759 women who did not have this diagnosis (control subjects).
RESULTS: Smoking, social class, and history of hypertension were found to be important risk factors for stroke. Women who had ever used oral contraceptives had an increased risk of all stroke (odds ratio, 1.5; 95% confidence interval, 1.1 to 2.0, adjusted for smoking and social class) and of a fatal event (adjusted odds ratio, 2.3; 95% confidence interval, 1.2 to 4.4). A significant doubling of all stroke risk was observed among current users, an effect that was apparent in both smokers and nonsmokers. Former users had a small nonsignificant elevation in risk of all stroke but a stronger risk of a fatal event. The effects in former users appeared to be restricted to women who smoked.
CONCLUSIONS: Current users of oral contraceptives appeared to be at increased risk of stroke. There is some evidence that former users may also have a persisting effect, although further research is needed to confirm these observations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165687     DOI: 10.1161/01.str.25.5.935

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

Review 1.  Is there an increased risk of stroke associated with oral contraceptives?

Authors:  K Zeitoun; B R Carr
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

2.  Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment.

Authors:  U Scoditti; G P Buccino; M Pini; C Pattacini; D Mancia
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 3.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives.

Authors:  P C Hannaford; V Owen-Smith
Journal:  BMJ       Date:  1998-03-28

4.  Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Jon Amastae; Michele Shedlin; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

Review 5.  The risk of stroke in patients with migraine and implications for migraine management.

Authors:  Gretchen E Tietjen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

7.  Effects of changes in smoking status on risk estimates for myocardial infarction among women recruited for the Royal College of General Practitioners' Oral Contraception Study in the UK.

Authors:  V Owen-Smith; P C Hannaford; M Warskyj; S Ferry; C R Kay
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

Review 8.  Stroke in women: risk and prevention throughout the lifespan.

Authors:  Cheryl D Bushnell
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

9.  Hypertension among oral contraceptive users in El Paso, Texas.

Authors:  Kari White; Joseph E Potter; Kristine Hopkins; Jon Amastae; Daniel Grossman
Journal:  J Health Care Poor Underserved       Date:  2013-11

10.  Association between number of children and carotid intima-media thickness in Bangladesh.

Authors:  Vylyny Chat; Fen Wu; Ryan T Demmer; Faruque Parvez; Alauddin Ahmed; Mahbub Eunus; Rabiul Hasan; Jabun Nahar; Ishrat Shaheen; Golam Sarwar; Moise Desvarieux; Habibul Ahsan; Yu Chen
Journal:  PLoS One       Date:  2018-11-27       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.